India Globalization Capital (NYSEAMERICAN:IGC) last announced its earnings results on Monday, November 20th. The construction company reported ($0.01) EPS for the quarter. The company had revenue of $0.24 million during the quarter. India Globalization Capital had a negative return on equity of 19.76% and a negative net margin of 128.96%.
India Globalization Capital (NYSEAMERICAN IGC) opened at $0.69 on Monday. The company has a market capitalization of $17.90, a P/E ratio of -9.81 and a beta of 2.44. India Globalization Capital has a 1-year low of $0.24 and a 1-year high of $1.63.
About India Globalization Capital
India Globalization Capital, Inc develops intellectual property for the treatment of life altering or life threatening conditions, through its research on phytocannabinoid-based therapies, in the United States. The Company also builds farming facilities for leasing. In Malaysia, the Company develops and manages residential and commercial real estate.
Receive News & Ratings for India Globalization Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for India Globalization Capital and related companies with MarketBeat.com's FREE daily email newsletter.